文献速递睡眠呼吸障碍

多夜监测揭示阻塞性睡眠呼吸暂停的患病率、变异性与诊断误分类

Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

研究基于消费者数据库中67,278名18-90岁购买床垫下睡眠分析仪的个体,进行平均约170夜的家庭夜间监测。结果显示全球中重度OSA患病率为22.6%(95%CI 20.9-24.3%),单夜诊断误分类率约20%-50%,监测14夜后误分类率稳定。

要点

  • 多夜家庭监测显示中重度OSA全球患病率约22.6%。
  • 单夜AHI诊断OSA的误分类率可达20%-50%。
  • 增加监测夜数可降低误分类,14夜后趋于稳定。

核心结论

  • 多夜家庭监测显示中重度OSA全球患病率约20%,单夜诊断约20%可能被误分类。

研究设计与样本

  • 研究纳入67,278名18-90岁个体,2020年7月至2021年3月进行家庭夜间监测,平均每人约170夜。

主要发现

  • 基于单夜AHI诊断OSA的误分类率约为20%至50%。

关键数值与推荐

  • OSA定义为夜间平均AHI大于15次/小时。
  • 单夜监测F1分数为0.77,14夜监测F1分数为0.94。

临床怎么用

  • 临床诊断和管理OSA时应考虑夜间变异性,避免仅凭单夜监测误判。

局限性

  • 样本来自消费者数据库,为非随机选择,可能影响代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Recent studies suggest that obstructive sleep apnea (OSA) severity can vary markedly from night to night, which may have important implications for diagnosis and management. Objectives: This study aimed to assess OSA prevalence from multinight in-home recordings and the impact of night-to-night variability in OSA severity on diagnostic classification in a large, global, nonrandomly selected community sample from a consumer database of people that purchased a novel, validated, under-mattress sleep analyzer. Methods: A total of 67,278 individuals aged between 18 and 90 years underwent in-home nightly monitoring over an average of approximately 170 nights per participant between July 2020 and March 2021. OSA was defined as a nightly mean apnea-hypopnea index (AHI) of more than 15 events/h. Outcomes were multinight global prevalence and likelihood of OSA misclassification from a single night's AHI value. Measurements and Main Results: More than 11.6 million nights of data were collected and analyzed. OSA global prevalence was 22.6% (95% confidence interval, 20.9-24.3%). The likelihood of misdiagnosis in people with OSA based on a single night ranged between approximately 20% and 50%. Misdiagnosis error rates decreased with increased monitoring nights (e.g., 1-night F1-score = 0.77 vs. 0.94 for 14 nights) and remained stable after 14 nights of monitoring. Conclusions: Multinight in-home monitoring using novel, noninvasive under-mattress sensor technology indicates a global prevalence of moderate to severe OSA of approximately 20%, and that approximately 20% of people diagnosed with a single-night study may be misclassified. These findings highlight the need to consider night-to-night variation in OSA diagnosis and management.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Lechat B, Naik G, Reynolds A, et al. Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2022. PMID: 34904935. doi:10.1164/rccm.202107-1761OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。